🇺🇸 FDA
Patent

US 11305002

Compositions and treatments for Haemophilus influenzae

granted A61KA61K39/102A61K9/0019

Quick answer

US patent 11305002 (Compositions and treatments for Haemophilus influenzae) held by The Board of Regents of the University of Oklahoma expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K39/102, A61K9/0019, A61P, A61P31/04